Warning Letter News
Most Popular Warning Letter Story
FDA letter vetoes Lilly API test
Eli Lilly is the recent recipient of an FDA warning letter concerning adulterated API at a manufacturing facility in Puerto Rico. In the letter, the regulator charges that the drug giant shipped 24... Read more...
Latest Headlines
- February 24, 2010
- January 26, 2010
- January 5, 2010
- December 1, 2009
- November 17, 2009
- November 12, 2009
- November 4, 2009
- November 4, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
